Toremifene Citrate
3 NDCs across 3 manufacturers|2 Generic,1 Brand
Toremifene Citrate is used to treat breast neoplasms and hormone-dependent neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 29, 1997, and the first generic was approved Dec 4, 2018. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $912K on Toremifene Citrate across 953 claims for 169 beneficiaries.
Toremifene Citrate is available as 3 NDCs from 3 manufacturers (2 generic, 1 brand), with NADAC prices from $19.60 to $41.13 per EA — the most expensive product costs about 2.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
3
competing in market
Price Spread
$19.60 – $41.13
per EA
7d Activity
avg -7.3% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Kyowa Kirin, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Estrogen Agonist/Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing TOREMIFENE CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FARESTON 60 MG TABLET | $41.1265 per EA | — |
TOREMIFENE CITRATE 60 MG TAB | $19.5989 per EA | -7.25% |
TOREMIFENE CITRATE 60 MG TAB | $19.5989 per EA | -7.25% |
Frequently Asked Questions
What is Toremifene Citrate used to treat?
Toremifene Citrate is used to treat breast neoplasms and hormone-dependent neoplasms, per the National Library of Medicine's MED-RT classification.
When did Toremifene Citrate become available as a generic?
FDA approved the first generic Toremifene Citrate (ANDA) on Dec 4, 2018. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Toremifene Citrate?
In 2024, Medicare Part D spent $912K on Toremifene Citrate across 953 claims for 169 beneficiaries.
How many Toremifene Citrate products are on the market?
The Toremifene Citrate drug market contains 3 NDCs from 3 manufacturers — 2 generic and 1 brand product.
What is the price range for Toremifene Citrate?
NADAC reference prices for Toremifene Citrate range from $19.5989 to $41.1265 per EA — the most expensive product costs about 2.1× the cheapest.
Is generic Toremifene Citrate cheaper than brand?
The average generic NADAC for Toremifene Citrate is $19.5989 per EA, versus $41.1265 for brand-labeled products — brand versions average about 2.1× the generic price.
Which manufacturers make Toremifene Citrate?
3 manufacturers list Toremifene Citrate in NADAC. Ranked by number of NDCs, the largest are Kyowa Kirin, Inc. (1), Rising Pharma Holdings Inc. (1), Novadoz Pharmaceuticals LLC (1).
How has the price of Toremifene Citrate changed recently?
Over the past 7 days, 0 Toremifene Citrate NDCs rose and 2 fell, with a market-wide average change of -7.3%.